← Leaderboards
Young-Kwon Hong
University Of Southern California
$14,910,487
Attributed
$15,587,796
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,367,233 · 12
By mechanism
R01$11,500,505 · 5
U54$5,779,437 · 1
R21$2,253,326 · 5
R38$1,833,965 · 1
Top collaborators
- Dhruv Singhal5 shared
- Ioannis Vlachos5 shared
- Fumito Ito2 shared
- Sanjeet Patel2 shared
- Michael Eugene Bowdish1 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Alex K. Wong$4,076,054
- Luping Zhao$138,598
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularAnimal ModelLymphaticBlood VesselsProgramsMediatingLymphatic VesselTissuesLymphatic SystemInsightBaseCellsAffectEndothelial CellsLymphatic Endothelial CellsDesignIn VitroProteinsSignal TransductionImmuneReportingKnockout MiceGene ExpressionMaintenance
Grant awards (48)
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,329,999
U54 · FY2025 · HL
Structural and Functional Studies of the Uterine Lymphatics$773,166
R01 · FY2025 · HL · contact PI
USC Stimulating Access to Research in Residency (USC-StARR) Program$379,741
R38 · FY2025 · HL
Structural and Functional Studies of the Uterine Lymphatics$24,672
R01 · FY2025 · HL · contact PI
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,749,517
U54 · FY2024 · HL
(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma$577,551
R01 · FY2024 · CA · contact PI
USC Stimulating Access to Research in Residency (USC-StARR) Program$363,556
R38 · FY2024 · HL
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,250,000
U54 · FY2023 · HL
(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma$577,551
R01 · FY2023 · CA · contact PI
USC Stimulating Access to Research in Residency (USC-StARR) Program$363,556
R38 · FY2023 · HL · contact PI
Multi-scale Spatial Mapping of Human Lymphatic Vessels$199,921
U54 · FY2023 · HL
Multi-scale Spatial Mapping of Human Lymphatic Vessels$1,250,000
U54 · FY2022 · HL
(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma$577,551
R01 · FY2022 · CA · contact PI
Effect of Brain Lymphatic Activation on Alzheimer's Disease Progression$453,750
R21 · FY2022 · AG · contact PI
Prox1 Phosphorylation in Lymphatic Development and Function$412,500
R01 · FY2022 · DK · contact PI
USC Stimulating Access to Research in Residency (USC-StARR) Program$363,556
R38 · FY2022 · HL · contact PI
(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma$188,374
R01 · FY2022 · CA · contact PI
(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma$577,551
R01 · FY2021 · CA · contact PI
Cooperative Regulation of Mechanotransduction for Lymphatic Valve Development by Prox1 and Nf-kB$412,500
R01 · FY2021 · HL · contact PI
Prox1 Phosphorylation in Lymphatic Development and Function$412,500
R01 · FY2021 · DK · contact PI
USC Stimulating Access to Research in Residency (USC-StARR) Program$363,556
R38 · FY2021 · HL
(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma$188,374
R01 · FY2021 · CA · contact PI
(PQ6) vGPCR-Mediated Paracrine Transformation for Kaposi Sarcoma$577,551
R01 · FY2020 · CA · contact PI
Prox1 Phosphorylation in Lymphatic Development and Function$412,500
R01 · FY2020 · DK · contact PI
Cooperative Regulation of Mechanotransduction for Lymphatic Valve Development by Prox1 and Nf-kB$412,500
R01 · FY2020 · HL · contact PI
Cooperative Regulation of Mechanotransduction for Lymphatic Valve Development by Prox1 and Nf-kB$648,780
R01 · FY2019 · HL · contact PI
Prox1 Phosphorylation in Lymphatic Development and Function$412,500
R01 · FY2019 · DK · contact PI
Study of CEACAM as Novel KSHV Receptors for Lymphatic Endothelial Cells$247,500
R21 · FY2019 · DE · contact PI
Cooperative Regulation of Mechanotransduction for Lymphatic Valve Development by Prox1 and Nf-kB$57,587
R01 · FY2019 · HL · contact PI
Cooperative Regulation of Mechanotransduction for Lymphatic Valve Development by Prox1 and Nf-kB$412,500
R01 · FY2018 · HL · contact PI
Prox1 Phosphorylation in Lymphatic Development and Function$412,500
R01 · FY2018 · DK · contact PI
Study of CEACAM as Novel KSHV Receptors for Lymphatic Endothelial Cells$206,250
R21 · FY2018 · DE · contact PI
Retinoic acid signaling in lymphangiogenesis$412,500
R01 · FY2017 · HL · contact PI
Flow Dependent Development and Maintenance of Schlemm's Canal$247,500
R21 · FY2017 · EY · contact PI
Retinoic acid signaling in lymphangiogenesis$412,500
R01 · FY2016 · HL · contact PI
Flow Dependent Development and Maintenance of Schlemm's Canal$206,250
R21 · FY2016 · EY · contact PI
Retinoic acid signaling in lymphangiogenesis$446,204
R01 · FY2015 · HL · contact PI
Early Detection and Intervention of Surgery-Induced Lymphatic Insufficiency$243,603
R21 · FY2015 · HL · contact PI
Retinoic acid signaling in lymphangiogenesis$410,625
R01 · FY2014 · HL · contact PI
Early Detection and Intervention of Surgery-Induced Lymphatic Insufficiency$207,469
R21 · FY2014 · HL · contact PI
Molecular Basis of Nuchal Edema$310,489
R01 · FY2013 · HD · contact PI
Molecular Basis of Nuchal Edema$327,175
R01 · FY2012 · HD · contact PI
Molecular Basis of Nuchal Edema$379,621
R01 · FY2011 · HD · contact PI
Molecular Basis of Nuchal Edema$341,860
R01 · FY2010 · HD · contact PI
Molecular Basis of Nuchal Edema$44,448
R01 · FY2010 · HD · contact PI
Molecular Basis of Nuchal Edema$346,375
R01 · FY2009 · HD · contact PI
A Lymphatic-specific fluorescent transgenic model$237,410
R21 · FY2007 · HL · contact PI
A Lymphatic-specific fluorescent transgenic model$203,594
R21 · FY2006 · HL · contact PI